EW
Edwards Lifesciences Corp
NYSE · Healthcare · Medical - Devices · US
$100.82
+1.46%Price chart
Oct 7Oct 12Oct 15Oct 20Oct 23Oct 28Nov 2Nov 5
Key dataNov 5, 2026
Open$101.40
From 52W high+0.00%
Volume9.15M
Market cap$58.11B
P/E (TTM)57.0x
P/S (TTM)8.7x
Div yield—
Key dataNov 5, 2026
Open
$101.40
From 52W high
+0.00%
Volume
9.15M
Market cap
$58.11B
ValuationView details →
P/E (Fwd)
31.0x
EV/EBITDA
47.2x
P/E (TTM)
57.0x
RSI (14)
75.5
MomentumView details →
1D Return
+1.46%
YTD Return
+18.49%
SummaryUpdated Sep 1, 2026
Edwards Lifesciences Corporation (NYSE:EW) is a leading medical device company founded in 1958 and headquartered in Irvine, California. The company has evolved from its origins as a division of American Hospital Supply Corporation to become a specialized leader in structural heart disease and critical care monitoring technologies. Edwards went public in 2000 and has since focused increasingly on structural heart therapies, completing the sale of its Critical Care business in 2024 to concentrate solely on treating heart valve diseases and related conditions.
Similar companies
Latest newsMore news →